[1] WANG B, ZHANG S, YUE K, et al.The recurrence and survival of oral squamous cell carcinoma:a report of 275 cases[J].Chin J Cancer, 2013, 32(11):614-618.
[2] MA F, WANG Z, ABDULARAB A, et al.Matrix metalloproteinase 9 and prostate cancer risk:a meta-analysis of 1059 participants[J].Minerva Urol Nefrol, 2017, 69(4):324-329.
[3] ZENG F C, CEN S, TANG Z Y, et al.Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer[J].Oncol Lett, 2016, 11(3):2213-2222.
[4] ZHANG X, LU J, ZHOU L, et al.Matrix metalloproteinase 11 as a novel tumor promoter and diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma[J].Pancreas, 2020, 49(6):812-821.
[5] 袁硕, 高炳菊, 李斌, 等.基质金属蛋白酶3在舌鳞状细胞癌中的表达及其临床意义[J].东南大学学报(医学版), 2022, 41(2):245-249.
[6] BARTOLOMÉ R A, FERREIRO S, MIQUILENA-COLINA M E, et al.The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs[J].Am J Pathol, 2009, 174(2):602-612.
[7] ALREHAILI A A, GHARIB A F, KARAM R A, et al.Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt[J].Mol Biol Rep, 2020, 47(2):1153-1160.
[8] WONG J P C, WEI R, LYU P, et al.Clinical and in vitro analysis of osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer[J].Int J Biol Sci, 2017, 13(11):1373-1386.
[9] LI H, QIU Z, LI F, et al.The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis[J].Oncol Lett, 2017, 14(5):5865-5870.
[10] ESCAFF S, FERNÁNDEZ J M, GONZÁLEZ L O, et al.Study of matrix metalloproteinases and their inhibitors in prostate cancer[J].Br J Cancer, 2010, 102(5):922-929.
[11] DENG H, GUO R F, LI W M, et al.Matrix metalloproteinase 11 depletion inhibits cellproliferation in gastric cancer cells[J].Biochem Biophys Res Commun, 2005, 326(2):274-281.
[12] YANG H, JIANG P, LIU D, et al.Matrix metalloproteinase 11 is a potential therapeutic target in lung adenocarcinoma[J].Mol Ther Oncolytics, 2019, 14:82-93.
[13] DENG W, PENG W, WANG T, et al.Overexpression of MMPs functions as a prognostic biomarker for oral cancer patients:a systematic review and meta-analysis[J].Oral Health Prev Dent, 2019, 17(6):505-514.
[14] HSIN C H, CHOU Y E, YANG S F, et al.MMP-11 promoted the oral cancer migration and Fak/Src activation[J].Oncotarget, 2017, 8(20):32783-32793.
[15] HSIN C H, CHEN M K, TANG C H, et al.High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma[J].PLoS One, 2014, 9(11):e113129.
[16] DONG H, DIAO H, ZHAO Y, et al.Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling[J].Cell Prolif, 2019, 52(5):e12633.
[17] LI L, WANG S, YANG X, et al.Traditional Chinese medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway[J].Mol Med Rep, 2017, 16(3):2461-2468.
[18] WANG W, LI D, XIANG L, et al.TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9[J].Cell Adh Migr, 2019, 13(1):273-284.
[19] HAN H B, GU J, ZUO H J, et al.Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer[J].J Pathol, 2012, 226(3):544-555. |